Human OAT1, OAT3, OAT4 and OATP1A2 Facilitate the Renal Accumulation of Ochratoxin A

<b>Background/Objectives</b>: Ochratoxin A (OTA) is a widespread foodborne mycotoxin linked to chronic kidney disease of unknown etiology. Despite evidence from animal models showing OTA accumulation in the kidney, the molecular mechanisms underlying its renal disposition in humans remain only partially understood. Here, we identify human renal transporters responsible for OTA kidney accumulation, elimination, and establish Michaelis-Menten kinetics under matched conditions to directly compare transport mechanisms. We also aim to identify inhibition potential of these transport mechanisms with common dietary polyphenols. <b>Methods</b>: Mammalian cells and membrane vesicles overexpressing human renal transporters were used to screen and profile the uptake and efflux of OTA. Miquelianin, (-)-Epicatechin-3-O-gallate, myricetin, luteolin, and caffeic acid were tested as potential concentration-dependent transporter inhibitors. <b>Results</b>: We demonstrate that OTA is a substrate for human organic anion transporter (hOAT) 1 (K<sub>m</sub>: 2.10 ± 0.50 μM, V<sub>max</sub>: 396.9 ± 27.0 pmol/mg/min), hOAT3 (K<sub>m</sub>: 2.58 ± 0.83 μM, V<sub>max</sub>: 141.4 ± 30.3 pmol/mg/min), hOAT4 (K<sub>m</sub>: 6.38 ± 1.45 μM, V<sub>max</sub>: 96.9 ± 18.8 pmol/mg/min), and human organic anion transporting polypeptide (hOATP) 1A2 (K<sub>m</sub>: 37.3 ± 6.2 μM, V<sub>max</sub>: 801.0 ± 133.9 pmol/mg/min). Among efflux transporters, OTA was transported only by human breast cancer resistance protein (hBCRP), which has minimal renal expression. While none of the uptake transporters were potently inhibited (>90%) by polyphenols at 10 μM, luteolin inhibited hBCRP-mediated transport of OTA with an IC<sub>50</sub> of 22 μM and caffeic acid stimulated hBCRP-mediated efflux with an EC<sub>50</sub> of 713.8 μM, both of which are physiologically relevant intestinal lumen concentrations. <b>Conclusions</b>: Our results confirm that exposure to OTA will lead to renal accumulation and increased health risks in affected populations, necessitating increased scrutiny of our food sources.

Authors

Institutions

Publication Details

Journal
Pharmaceutics
Published
2025-11-16
DOI
https://doi.org/10.3390/pharmaceutics17111474
Primary Topic
Mycotoxins in Agriculture and Food
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Human OAT1, OAT3, OAT4 and OATP1A2 Facilitate the Renal Accumulation of Ochratoxin A

Zsuzsanna Gáborik, Anish Mahadeo, Yik Pui Tsang, Edward J. Kelly et al.
Pharmaceutics
Mycotoxins in Agriculture and Food
article

Human OAT1, OAT3, OAT4 and OATP1A2 Facilitate the Renal Accumulation of Ochratoxin A

Zsuzsanna Gáborik, Anish Mahadeo, Yik Pui Tsang, Edward J. Kelly, Sydney Arnzen, Acilegna G. Rodriguez, Mark S. Warren, Angela Zheng
article en

Abstract

<b>Background/Objectives</b>: Ochratoxin A (OTA) is a widespread foodborne mycotoxin linked to chronic kidney disease of unknown etiology. Despite evidence from animal models showing OTA accumulation in the kidney, the molecular mechanisms underlying its renal disposition in humans remain only partially understood. Here, we identify human renal transporters responsible for OTA kidney accumulation, elimination, and establish Michaelis-Menten kinetics under matched conditions to directly compare transport mechanisms. We also aim to identify inhibition potential of these transport mechanisms with common dietary polyphenols. <b>Methods</b>: Mammalian cells and membrane vesicles overexpressing human renal transporters were used to screen and profile the uptake and efflux of OTA. Miquelianin, (-)-Epicatechin-3-O-gallate, myricetin, luteolin, and caffeic acid were tested as potential concentration-dependent transporter inhibitors. <b>Results</b>: We demonstrate that OTA is a substrate for human organic anion transporter (hOAT) 1 (K<sub>m</sub>: 2.10 ± 0.50 μM, V<sub>max</sub>: 396.9 ± 27.0 pmol/mg/min), hOAT3 (K<sub>m</sub>: 2.58 ± 0.83 μM, V<sub>max</sub>: 141.4 ± 30.3 pmol/mg/min), hOAT4 (K<sub>m</sub>: 6.38 ± 1.45 μM, V<sub>max</sub>: 96.9 ± 18.8 pmol/mg/min), and human organic anion transporting polypeptide (hOATP) 1A2 (K<sub>m</sub>: 37.3 ± 6.2 μM, V<sub>max</sub>: 801.0 ± 133.9 pmol/mg/min). Among efflux transporters, OTA was transported only by human breast cancer resistance protein (hBCRP), which has minimal renal expression. While none of the uptake transporters were potently inhibited (>90%) by polyphenols at 10 μM, luteolin inhibited hBCRP-mediated transport of OTA with an IC<sub>50</sub> of 22 μM and caffeic acid stimulated hBCRP-mediated efflux with an EC<sub>50</sub> of 713.8 μM, both of which are physiologically relevant intestinal lumen concentrations. <b>Conclusions</b>: Our results confirm that exposure to OTA will lead to renal accumulation and increased health risks in affected populations, necessitating increased scrutiny of our food sources.

PharmaceuticsVol. 17(11)
Applied Materials (United States) (US), University of Washington (US), Kidney Research UK (GB), Solvo Biotechnology (Hungary) (HU)
University of Washington, National Institutes of Health, National Institute of Environmental Health Sciences, National Center for Advancing Translational Sciences
Openalex Percentile: Top 75%
Mycotoxins in Agriculture and Food
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.